{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,11]],"date-time":"2026-04-11T09:02:11Z","timestamp":1775898131480,"version":"3.50.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2010,7,10]],"date-time":"2010-07-10T00:00:00Z","timestamp":1278720000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Treat Options Neurol"],"published-print":{"date-parts":[[2010,9]]},"DOI":"10.1007\/s11940-010-0086-5","type":"journal-article","created":{"date-parts":[[2010,7,9]],"date-time":"2010-07-09T08:54:39Z","timestamp":1278665679000},"page":"464-474","source":"Crossref","is-referenced-by-count":8,"title":["Meningococcal Meningitis"],"prefix":"10.1007","volume":"12","author":[{"given":"Ricardo G.","family":"Branco","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert C.","family":"Tasker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,7,10]]},"reference":[{"issue":"2","key":"86_CR1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1086\/649209","volume":"50","author":"AC Cohn","year":"2010","unstructured":"Cohn AC, MacNeil JR, Harrison LH, et al.: Changes in Neisseria meningitidis disease epidemiology in the United States, 1998\u20132007: implications for prevention of meningococcal disease. Clin Infect Dis 2010, 50(2):184\u2013191.","journal-title":"Clin Infect Dis"},{"issue":"3","key":"86_CR2","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1586\/erv.10.3","volume":"9","author":"A Khatami","year":"2010","unstructured":"Khatami A, Pollard AJ: The epidemiology of meningococcal disease and the impact of vaccines. Expert Rev Vaccines 2010, 9(3):285\u2013298.","journal-title":"Expert Rev Vaccines"},{"issue":"9580","key":"86_CR3","doi-asserted-by":"crossref","first-page":"2196","DOI":"10.1016\/S0140-6736(07)61016-2","volume":"369","author":"DS Stephens","year":"2007","unstructured":"Stephens DS, Greenwood B, Brandtzaeg P: Epidemic meningitis, meningococcaemia, and Neisseria meningitidis. Lancet 2007, 369(9580):2196\u20132210.","journal-title":"Lancet"},{"issue":"6","key":"86_CR4","doi-asserted-by":"crossref","first-page":"950","DOI":"10.3201\/eid1206.051297","volume":"12","author":"J MacLennan","year":"2006","unstructured":"MacLennan J, Kafatos G, Neal K, et al.: Social behavior and meningococcal carriage in British teenagers. Emerg Infect Dis 2006, 12(6):950\u2013957.","journal-title":"Emerg Infect Dis"},{"issue":"4","key":"86_CR5","first-page":"274","volume":"7","author":"M Virji","year":"2009","unstructured":"Virji M: Pathogenic neisseriae: surface modulation, pathogenesis and infection control. Nat Rev 2009, 7(4):274\u2013286.","journal-title":"Nat Rev"},{"issue":"1","key":"86_CR6","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1128\/CMR.13.1.144","volume":"13","author":"M Deuren van","year":"2000","unstructured":"van Deuren M, Brandtzaeg P, van der Meer JW: Update on meningococcal disease with emphasis on pathogenesis and clinical management. Clin Microbiol Rev 2000, 13(1):144\u2013166.","journal-title":"Clin Microbiol Rev"},{"issue":"18","key":"86_CR7","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1056\/NEJM200105033441807","volume":"344","author":"NE Rosenstein","year":"2001","unstructured":"Rosenstein NE, Perkins BA, Stephens DS, et al.: Meningococcal disease. N Engl J Med 2001, 344(18):1378\u20131388.","journal-title":"N Engl J Med"},{"issue":"4","key":"86_CR8","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1097\/MD.0b013e318180a6b4","volume":"87","author":"SG Heckenberg","year":"2008","unstructured":"Heckenberg SG, de Gans J, Brouwer MC, et al.: Clinical features, outcome, and meningococcal genotype in 258 adults with meningococcal meningitis: a prospective cohort study. Medicine 2008, 87(4):185\u2013192.","journal-title":"Medicine"},{"issue":"9508","key":"86_CR9","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S0140-6736(06)67932-4","volume":"367","author":"MJ Thompson","year":"2006","unstructured":"Thompson MJ, Ninis N, Perera R, et al.: Clinical recognition of meningococcal disease in children and adolescents. Lancet 2006, 367(9508):397\u2013403.","journal-title":"Lancet"},{"issue":"1","key":"86_CR10","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMra052116","volume":"354","author":"D Beek van de","year":"2006","unstructured":"van de Beek D, de Gans J, Tunkel AR, Wijdicks EF: Community-acquired bacterial meningitis in adults. N Engl J Med 2006, 354(1):44\u201353.","journal-title":"N Engl J Med"},{"issue":"7","key":"86_CR11","doi-asserted-by":"crossref","first-page":"2980","DOI":"10.1128\/JCM.42.7.2980-2987.2004","volume":"42","author":"R Ovstebo","year":"2004","unstructured":"Ovstebo R, Brandtzaeg P, Brusletto B, et al.: Use of robotized DNA isolation and real-time PCR to quantify and identify close correlation between levels of Neisseria meningitidis DNA and lipopolysaccharides in plasma and cerebrospinal fluid from patients with systemic meningococcal disease. J Clin Microbiol 2004, 42(7):2980\u20132987.","journal-title":"J Clin Microbiol"},{"issue":"4","key":"86_CR12","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1093\/qjmed\/hci047","volume":"98","author":"N Proulx","year":"2005","unstructured":"Proulx N, Frechette D, Toye B, et al.: Delays in the administration of antibiotics are associated with mortality from adult acute bacterial meningitis. QJM 2005, 98(4):291\u2013298.","journal-title":"QJM"},{"issue":"Pt 7","key":"86_CR13","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1099\/jmm.0.46288-0","volume":"55","author":"SJ Gray","year":"2006","unstructured":"Gray SJ, Trotter CL, Ramsay ME, et al.: Epidemiology of meningococcal disease in England and Wales 1993\/94 to 2003\/04: contribution and experiences of the Meningococcal Reference Unit. J Med Microbiol 2006, 55(Pt 7):887\u2013896.","journal-title":"J Med Microbiol"},{"issue":"10","key":"86_CR14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/j.trstmh.2006.03.002","volume":"100","author":"T Borel","year":"2006","unstructured":"Borel T, Rose AM, Guillerm M, et al.: High sensitivity and specificity of the Pastorex latex agglutination test for Neisseria meningitidis serogroup A during a clinical trial in Niger. Trans R Soc Trop Med Hyg 2006, 100(10):964\u2013969.","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"86_CR15","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1186\/1471-2458-9-95","volume":"9","author":"E Perea-Milla","year":"2009","unstructured":"Perea-Milla E, Olalla J, Sanchez-Cantalejo E, et al.: Pre-hospital antibiotic treatment and mortality caused by invasive meningococcal disease, adjusting for indication bias. BMC Public Health 2009, 9:95.","journal-title":"BMC Public Health"},{"key":"86_CR16","first-page":"CD005437","volume":"1","author":"T Sudarsanam","year":"2008","unstructured":"Sudarsanam T, Rupali P, Tharyan P, et al.: Pre-admission antibiotics for suspected cases of meningococcal disease. Cochrane Database Syst Rev 2008, 1:CD005437.","journal-title":"Cochrane Database Syst Rev"},{"issue":"3","key":"86_CR17","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1128\/AAC.01077-09","volume":"54","author":"EM Brown","year":"2010","unstructured":"Brown EM, Fisman DN, Drews SJ, et al.: Epidemiology of invasive meningococcal disease with decreased susceptibility to penicillin in Ontario, Canada, 2000 to 2006. Antimicrob Agents Chemother 2010, 54(3):1016\u20131021.","journal-title":"Antimicrob Agents Chemother"},{"issue":"5","key":"86_CR18","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1086\/377203","volume":"37","author":"R Ellis-Pegler","year":"2003","unstructured":"Ellis-Pegler R, Galler L, Roberts S, et al.: Three days of intravenous benzyl penicillin treatment of meningococcal disease in adults. Clin Infect Dis 2003, 37(5):658\u2013662.","journal-title":"Clin Infect Dis"},{"issue":"10","key":"86_CR19","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1157\/13054548","volume":"21","author":"N Stella-Silvaa","year":"2003","unstructured":"Stella-Silvaa N, Oliveiraa SA, Feldman-Marzochib KB: Meningococcal disease: clinicopathological correlation] [in Spanish. Enferm Infecc Microbiol Clin 2003, 21(10):557\u2013562.","journal-title":"Enferm Infecc Microbiol Clin"},{"issue":"2 Suppl","key":"86_CR20","doi-asserted-by":"crossref","first-page":"S46","DOI":"10.2223\/JPED.1612","volume":"83","author":"RG Branco","year":"2007","unstructured":"Branco RG, Amoretti CF, Tasker RC: Meningococcal disease and meningitis. J Pediatr (Rio J) 2007, 83(2 Suppl):S46\u2013S53.","journal-title":"J Pediatr (Rio J)"},{"key":"86_CR21","first-page":"CD004405","volume":"1","author":"D Beek van de","year":"2007","unstructured":"van de Beek D, de Gans J, McIntyre P, Prasad K: Corticosteroids for acute bacterial meningitis. Cochrane Database Syst Rev 2007, 1:CD004405.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"86_CR22","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ncpneuro0767","volume":"4","author":"D Beek van de","year":"2008","unstructured":"van de Beek D, de Gans J: Should adults with suspected bacterial meningitis receive adjunctive dexamethasone? Nat Clin Pract 2008, 4(5):252\u2013253.","journal-title":"Nat Clin Pract"},{"issue":"20","key":"86_CR23","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","volume":"347","author":"J Gans de","year":"2002","unstructured":"de Gans J, van de Beek D: Dexamethasone in adults with bacterial meningitis. N Engl J Med 2002, 347(20):1549\u20131556.","journal-title":"N Engl J Med"},{"issue":"1","key":"86_CR24","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S1473-3099(09)70306-8","volume":"10","author":"KS Kim","year":"2010","unstructured":"Kim KS: Acute bacterial meningitis in infants and children. Lancet Infect Dis 2010, 10(1):32\u201342.","journal-title":"Lancet Infect Dis"},{"issue":"6","key":"86_CR25","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1097\/CCM.0b013e31817603ba","volume":"36","author":"PE Marik","year":"2008","unstructured":"Marik PE, Pastores SM, Annane D, et al.: Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine. Crit Care Med 2008, 36(6):1937\u20131949.","journal-title":"Crit Care Med"},{"issue":"11","key":"86_CR26","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1136\/adc.2005.077701","volume":"90","author":"RG Branco","year":"2005","unstructured":"Branco RG, Russell RR: Should steroids be used in children with meningococcal shock? Arch Dis Child 2005, 90(11):1195\u20131196.","journal-title":"Arch Dis Child"},{"issue":"5","key":"86_CR27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1034\/j.1399-6576.2002.460515.x","volume":"46","author":"K Moller","year":"2002","unstructured":"Moller K, Strauss GI, Thomsen G, et al.: Cerebral blood flow, oxidative metabolism and cerebrovascular carbon dioxide reactivity in patients with acute bacterial meningitis. Acta Anaesthesiol Scand 2002, 46(5):567\u2013578.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"3","key":"86_CR28","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.0954-6820.1974.tb00994.x","volume":"196","author":"OB Paulson","year":"1974","unstructured":"Paulson OB, Brodersen P, Hansen EL, Kristensen HS: Regional cerebral blood flow, cerebral metabolic rate of oxygen, and cerebrospinal fluid acid-base variables in patients with acute meningitis and with acute encephalitis. Acta Med Scand 1974, 196(3):191\u2013198.","journal-title":"Acta Med Scand"},{"issue":"6","key":"86_CR29","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1542\/peds.2005-2179","volume":"117","author":"FO Odetola","year":"2006","unstructured":"Odetola FO, Tilford JM, Davis MM: Variation in the use of intracranial-pressure monitoring and mortality in critically ill children with meningitis in the United States. Pediatrics 2006, 117(6):1893\u20131900.","journal-title":"Pediatrics"},{"issue":"1","key":"86_CR30","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/s00134-004-2501-4","volume":"31","author":"FO Odetola","year":"2005","unstructured":"Odetola FO, Bratton SL: Characteristics and immediate outcome of childhood meningitis treated in the pediatric intensive care unit. Intensive Care Med 2005, 31(1):92\u201397.","journal-title":"Intensive Care Med"},{"issue":"10","key":"86_CR31","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJM200103083441001","volume":"344","author":"GR Bernard","year":"2001","unstructured":"Bernard GR, Vincent JL, Laterre PF, et al.: Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 2001, 344(10):699\u2013709.","journal-title":"N Engl J Med"},{"issue":"4","key":"86_CR32","doi-asserted-by":"crossref","first-page":"R331","DOI":"10.1186\/cc3538","volume":"9","author":"JL Vincent","year":"2005","unstructured":"Vincent JL, Nadel S, Kutsogiannis DJ, et al.: Drotrecogin alfa (activated) in patients with severe sepsis presenting with purpura fulminans, meningitis, or meningococcal disease: a retrospective analysis of patients enrolled in recent clinical studies. Crit Care 2005, 9(4):R331\u2013R343.","journal-title":"Crit Care"},{"issue":"9564","key":"86_CR33","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/S0140-6736(07)60411-5","volume":"369","author":"S Nadel","year":"2007","unstructured":"Nadel S, Goldstein B, Williams MD, et al.: Drotrecogin alfa (activated) in children with severe sepsis: a multicentre phase III randomised controlled trial. Lancet 2007, 369(9564):836\u2013843.","journal-title":"Lancet"},{"issue":"8","key":"86_CR34","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa012689","volume":"346","author":"Hypothermia after Cardiac Arrest Study Group","year":"2002","unstructured":"Hypothermia after Cardiac Arrest Study Group: Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest. N Engl J Med 2002, 346(8):549\u2013556.","journal-title":"N Engl J Med"},{"issue":"8","key":"86_CR35","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1056\/NEJMoa003289","volume":"346","author":"SA Bernard","year":"2002","unstructured":"Bernard SA, Gray TW, Buist MD, et al.: Treatment of comatose survivors of out-of-hospital cardiac arrest with induced hypothermia. N Engl J Med 2002, 346(8):557\u2013563.","journal-title":"N Engl J Med"},{"issue":"14","key":"86_CR36","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJMoa0900854","volume":"361","author":"DV Azzopardi","year":"2009","unstructured":"Azzopardi DV, Strohm B, Edwards AD, et al.: Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med 2009, 361(14):1349\u20131358.","journal-title":"N Engl J Med"},{"issue":"1","key":"86_CR37","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/PCC.0b013e3181c8790c","volume":"11","author":"AD Ackerman","year":"2010","unstructured":"Ackerman AD, Singhi S: Pediatric infectious diseases: 2009 update for the Rogers\u2019 Textbook of Pediatric Intensive Care. Pediatr Crit Care Med 2010, 11(1):117\u2013123.","journal-title":"Pediatr Crit Care Med"},{"issue":"10","key":"86_CR38","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1086\/522534","volume":"45","author":"H Peltola","year":"2007","unstructured":"Peltola H, Roine I, Fernandez J, et al.: Adjuvant glycerol and\/or dexamethasone to improve the outcomes of childhood bacterial meningitis: a prospective, randomized, double-blind, placebo-controlled trial. Clin Infect Dis 2007, 45(10):1277\u20131286.","journal-title":"Clin Infect Dis"}],"container-title":["Current Treatment Options in Neurology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0086-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11940-010-0086-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11940-010-0086-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T05:19:15Z","timestamp":1711603155000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11940-010-0086-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,7,10]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2010,9]]}},"alternative-id":["86"],"URL":"https:\/\/doi.org\/10.1007\/s11940-010-0086-5","relation":{},"ISSN":["1092-8480","1534-3138"],"issn-type":[{"value":"1092-8480","type":"print"},{"value":"1534-3138","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,7,10]]}}}